- Home
- ERII vs PRME Comparison
ERII vs PRME Comparison
Compare ERII & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERII
- PRME
- Stock Information
- Founded
- ERII 1992
- PRME 2019
- Country
- ERII United States
- PRME United States
- Employees
- ERII N/A
- PRME N/A
- Industry
- ERII Industrial Machinery/Components
- PRME Medicinal Chemicals and Botanical Products
- Sector
- ERII Technology
- PRME Health Care
- Exchange
- ERII Nasdaq
- PRME Nasdaq
- Market Cap
- ERII 801.2M
- PRME 693.5M
- IPO Year
- ERII 2008
- PRME 2022
- Fundamental
- Price
- ERII $15.45
- PRME $5.95
- Analyst Decision
- ERII Buy
- PRME Buy
- Analyst Count
- ERII 4
- PRME 6
- Target Price
- ERII $18.75
- PRME $8.88
- AVG Volume (30 Days)
- ERII 440.9K
- PRME 3.9M
- Earning Date
- ERII 10-29-2025
- PRME 11-11-2025
- Dividend Yield
- ERII N/A
- PRME N/A
- EPS Growth
- ERII 25.10
- PRME N/A
- EPS
- ERII 0.43
- PRME N/A
- Revenue
- ERII $141,775,000.00
- PRME $4,961,000.00
- Revenue This Year
- ERII $6.16
- PRME $179.58
- Revenue Next Year
- ERII $13.06
- PRME N/A
- P/E Ratio
- ERII $36.58
- PRME N/A
- Revenue Growth
- ERII 6.19
- PRME 739.42
- 52 Week Low
- ERII $10.86
- PRME $1.11
- 52 Week High
- ERII $20.27
- PRME $6.94
- Technical
- Relative Strength Index (RSI)
- ERII 59.81
- PRME 63.82
- Support Level
- ERII $15.22
- PRME $4.87
- Resistance Level
- ERII $16.28
- PRME $6.94
- Average True Range (ATR)
- ERII 0.41
- PRME 0.49
- MACD
- ERII 0.02
- PRME 0.08
- Stochastic Oscillator
- ERII 53.67
- PRME 55.90
About ERII Energy Recovery Inc.
Energy Recovery Inc is an engineering-driven technology company. It is engaged in engineering, designing, manufacturing and supplying solutions that make industrial processes more efficient and sustainable. The company operates in three segments, Water, Emerging Technologies and Corporate. It offers energy recovery devices (ERDs) and pumps as well as related products and services to the reverse osmosis desalination market. The company derives a majority of the revenue from the Water segment. Geographically, the company operates in the U.S. and other international countries.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.